title: Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells.
abstract: Fatty acid synthase (FASN) is the metabolic enzyme responsible for the endogenous synthesis of the saturated long-chain fatty acid palmitate. In contrast to most normal cells, FASN is overexpressed in a variety of human cancers including cutaneous melanoma, in which its levels of expression are associated with a poor prognosis and depth of invasion. Recently, we have demonstrated the mitochondrial involvement in FASN inhibition-induced apoptosis in melanoma cells. Herein we compare, via electrospray ionization mass spectrometry (ESI-MS), free fatty acids (FFA) composition of mitochondria isolated from control (EtOH-treated cells) and Orlistat-treated B16-F10 mouse melanoma cells. Principal component analysis (PCA) was applied to the ESI-MS data and found to separate the two groups of samples. Mitochondria from control cells showed predominance of six ions, that is, those of m/z 157 (Pelargonic, 9:0), 255 (Palmitic, 16:0), 281 (Oleic, 18:1), 311 (Arachidic, 20:0), 327 (Docosahexaenoic, 22:6) and 339 (Behenic, 22:0). In contrast, FASN inhibition with Orlistat changes significantly mitochondrial FFA composition by reducing synthesis of palmitic acid, and its elongation and unsaturation products, such as arachidic and behenic acids, and oleic acid, respectively. ESI-MS of mitochondria isolated from Orlistat-treated cells presented therefore three major ions of m/z 157 (Pelargonic, 9:0), 193 (unknown) and 199 (Lauric, 12:0). These findings demonstrate therefore that FASN inhibition by Orlistat induces significant changes in the FFA composition of mitochondria.
authors.affiliation: Departamento de Diagnóstico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas (UNICAMP), Piracicaba, SP, 13414-018, Brazil. kgzecchin@yahoo.com
authors.forename: Karina G
authors.initials: KG
authors.lastname: Zecchin
authors.forename: Luciane C
authors.initials: LC
authors.lastname: Alberici
authors.forename: Maria Francesca
authors.initials: MF
authors.lastname: Riccio
authors.forename: Marcos N
authors.initials: MN
authors.lastname: Eberlin
authors.forename: Aníbal E
authors.initials: AE
authors.lastname: Vercesi
authors.forename: Edgard
authors.initials: E
authors.lastname: Graner
authors.forename: Rodrigo R
authors.initials: RR
authors.lastname: Catharino
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D000431:Ethanol / Q000737:chemistry; D064429:Fatty Acid Synthases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005227:Fatty Acids / Q000737:chemistry / Q000378:metabolism; D007783:Lactones / Q000494:pharmacology; D013058:Mass Spectrometry / Q000379:methods*; D008545:Melanoma / Q000201:enzymology*; D051379:Mice; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology*; D000077403:Orlistat; D025341:Principal Component Analysis
chemical_list: D005227:Fatty Acids; D007783:Lactones; D000431:Ethanol; D000077403:Orlistat; D064429:Fatty Acid Synthases